Connor, Clark & Lunn Investment Management Ltd.

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1596800 VANCOUVER, A1

Position in RYTM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$15,085,313

+$1,879,615 QoQ

Shares Held

135,867

-10.5% QoQ

Ownership

0.197%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $648,992,404 across 104 Biotechnology names. RYTM ranks #15 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,085,313	135,867	-10.5%	Shares	Sole	2026-08-13
2026-03-31	$13,205,698	151,842	+1.7%	Shares	Sole	2026-05-11
2025-12-31	$15,988,885	149,373	+23.2%	Shares	Sole	2026-02-10
2025-09-30	$12,246,047	121,260	+5.3%	Shares	Sole	2025-11-13
2025-06-30	$7,274,306	115,118	+127.7%	Shares	Sole	2025-08-07
2025-03-31	$2,678,004	50,557	+730.3%	Shares	Sole	2025-05-12
2024-12-31	$340,862	6,089	-34.8%	Shares	Sole	2025-02-10
2024-06-30	$383,500	9,340	-3.5%	Shares	Sole	2024-08-09
2024-03-31	$419,217	9,675	-85.2%	Shares	Sole	2024-05-09
2023-12-31	$3,013,057	65,544	-50.2%	Shares	Sole	2024-02-09
2023-09-30	$3,018,351	131,662	+126.5%	Shares	Sole	2023-11-13
2023-06-30	$958,382	58,119	+417.8%	Shares	Sole	2023-08-10
2022-06-30	$46,583	11,225	—	Shares	Sole	2022-08-05
No filing history on record for this holder in this stock.